[Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4-4602, amantadine)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D001545:Benserazide / Q000627:therapeutic use; D002570:Ceruloplasmin / Q000134:cerebrospinal fluid / Q000378:metabolism*; D002648:Child; D003300:Copper / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D007501:Iron / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy* / Q000378:metabolism; D009135:Muscular Diseases / Q000188:drug therapy* / Q000378:metabolism; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D014168:Transferrin / Q000134:cerebrospinal fluid / Q000378:metabolism*
D006834:Hydrazines; D014168:Transferrin; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D003300:Copper; D000547:Amantadine; D007501:Iron; D002570:Ceruloplasmin
Ferro, transferrina, rame e ceruloplasmina del siero e del liquor nelle malattie extrapiramidali e nelle miopatie primitive.